Ruxolitinib cream with steroids for active vitiligo on face
Part of Skin clinical trials.
This trial tests a cream (ruxolitinib) combined with corticosteroid treatment for people with active, non-segmental vitiligo that affects the face. It aims to see how well this combination works in real-world settings.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 12 years or older.
- You have non-segmental vitiligo (patches on both sides of the body) with some on your face.
- Your vitiligo is active or getting worse (e.g., new spots, spreading).
- The total amount of white skin is less than 10% of your body surface.
- You agree to use birth control if needed and follow study visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an oral medication (a tablet) for treating non-segmental vitiligo, a condition where white patches appear on the skin. The goal is to see if the drug can safely help bring color back to those patches.
This trial tests a cream called ruxolitinib for adults with vitiligo on the face and neck that has not responded well to another cream (tacrolimus). The goal is to see if this cream can help bring back skin color.
This study tests a cream called ruxolitinib for children with nonsegmental vitiligo. It aims to see if the cream can safely help restore skin color in affected areas.
This study tests whether a cream called ruxolitinib can help children ages 6 to 11 with nonsegmental vitiligo. It aims to see if the cream safely restores color to white patches on the face and body.
This study tests how well a cream called ruxolitinib works for vitiligo in real-world conditions. It looks at what factors might make the treatment more or less effective.
This trial tests a cream called ruxolitinib to see if it can safely and effectively restore skin color in children with vitiligo. It may help reduce white patches on the skin.
Hear when a new Non-Segmental Vitiligo (NSV) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.